PROFESSIONAL EDITION

The largest community of pharma leaders

Industry News

Exicure Granted Orphan Drug Designation by the U.S. Food and Drug Administration for Cavrotolimod

CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced...

Shorla Pharma Announces U.S. Industry Veteran Nicholas Holsman as Chief Commercial Officer

CLONMEL, Ireland--(BUSINESS WIRE)--Shorla Pharma Limited (‘Shorla’), a specialty pharmaceutical company, announces the appointment of Chief Commercial Officer Nicholas Holsman, a highly experienced U.S. industry...

FDA Approves Investigational New Drug (IND) for Neuroendocrine Tumors from Molecular Targeting Technologies, Inc.

WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI), a clinical stage radiopharmaceutical therapy company focused on therapies for rare diseases, announced today the approval...

Recent Articles